Study to Evaluate the Effect of Voxelotor Administered Orally to Patients With Sickle Cell Disease (GBT_HOPE)

Clinical trial NCT03036813 · COMPLETED

Trial details

NCT number: NCT03036813
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2016-12-01
Primary completion: 2019-10-08
Enrollment: 449

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.